Email Updates

Search form

You are here

AVAC in the News

  • The International AIDS Society (IAS) has appointed five leaders in HIV prevention research, implementation and advocacy as Co-Chairs for the HIV Research for Prevention (HIVR4P) conference.

    February 22, 2019
    General
    PM News
  • During the State of the Union address tonight, President Trump is expected to call for an end to the spread of HIV in the U.S. by 2030. There's a drug already on the market that could help make that a reality. It's called Truvada -- otherwise known as PrEP (for Pre-Exposure Prophylaxis) -- and when taken as a preventive, it can drastically reduces transmission of HIV.... The downside? It can cost upward of $1,600 a month.

    February 5, 2019
    Marketplace
  • The imperative of continuous medical research and efforts, accompanied by comprehensive enlightenment and educational programmes, toward curtailing the intractable HIV/AIDS pandemic in the world cannot be over emphasised. This is the reason organisations around the world such as the WHO, AVAC, USAID, PEPFAR, CRH and so on devote much energy and resources to fights against the scourge.

    January 29, 2019
    General
    PM News
  • To stem the tides of HIV/AIDS prevalence in Nigeria, a non-governmental organisation, AVAC, in collaboration with the Centre for The Right to Health (CRH), has taken up the gauntlet to lead advocacy against the disease which, according to medical research, is having upper hand on the most productive section of the country’s population—the youth.

    January 24, 2019
    General
    PM News
  • On the prevention front, our options have never been better. We currently have daily oral PrEP (pre-exposure prophylaxis), condoms, and U=U (undetectable equals untransmittable). But what if we could make HIV prevention even more accessible and easier to take? We spoke with a few providers and experts to see what’s currently on the horizon for HIV treatment and prevention.

    January 1, 2019
    Antibody Related Research, HIV Vaccine, Microbicides, PrEP, Treatment
    Positively Aware
  • Michel Sidibé, executive director of UNAIDS, the agency overseeing the global response to the HIV/AIDS epidemic, will step down from his post in June 2019, the agency announced yesterday (13 December).

    December 14, 2018
    General
    SciDevNet
  • Unprecedented progress has happened in fight against AIDS globally, but formidable challenges remain. Are we making enough progress on HIV prevention, treatment and care, in communities and places where HIV incidence is likely to be higher?

    December 11, 2018
    General
    Social Post
  • Collaboration, combination prevention, and choice were the maxims of HIVR4P in Madrid, Oct 21–25, where over 1400 delegates gathered to discuss biomedical HIV prevention approaches.

    December 6, 2018
    General
    Lancet HIV
  • A new generation of drug buyers’ clubs like those set up at the height of the AIDS epidemic is seeking to combat a “crisis” in preventing new HIV infections by providing access to cheap generics of a breakthrough prophylactic.

    December 3, 2018
    Reuters
  • We could be just months away from knowing whether Depo-Provera use is linked to a higher risk of HIV infection in women.

    November 23, 2018
    Bhekisisa

Pages